New Publication in PNAS, a bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritis
January 10, 2023
READ ARTICLEThe peptide industry leaders at AmbioPharm, Inc. regularly share items of interest, in the AmbioPharm blog, to the peptide research, peptide API manufacturing, pharmaceutical, and clinical research industries. Check here for our latest research, industry leadership and blog articles of interest. Click here to stay up to date on recent AmbioPharm news.
January 10, 2023
READ ARTICLE
January 3, 2023
READ ARTICLETHE AMBIOPHARM BLOG
November 1, 2022
READ ARTICLE
October 19, 2022
READ ARTICLE
September 27, 2022
READ ARTICLE
August 3, 2022
READ ARTICLE
June 13, 2022
READ ARTICLESETTING A NEW STANDARD